<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sideroblastic anemia classification by MCV</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sideroblastic anemia classification by MCV</h1>
<div class="graphic"><div class="figure"><div class="ttl">Sideroblastic anemia classification by MCV</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1">Sideroblastic anemia</td> <td class="subtitle1">Clinical features</td> <td class="subtitle1">Diagnostic testing</td> </tr> <tr> <td class="subtitle2_left" colspan="3">MCV decreased</td> </tr> <tr> <td class="indent1">Isoniazid</td> <td>History of use</td> <td>Response to discontinuation and/or vitamin B6 supplementation</td> </tr> <tr> <td class="indent1">X-linked sideroblastic anemia (XLSA) in males</td> <td>Family history (no syndromic features); usually adult presentation</td> <td><em>ALAS2</em> mutation analysis</td> </tr> <tr> <td class="indent1">XLSA/A</td> <td>Family history; ataxia; childhood presentation</td> <td><em>ABCB7</em> mutation analysis</td> </tr> <tr> <td class="indent1">Autosomal recessive congenital sideroblastic anemia (ARCSA)</td> <td>Family history; infancy, childhood, or adult presentation (no syndromic features)</td> <td><em>SLC25A38</em>, <em>HSPA9</em>, <em>HSCB</em>, <em>GLRX5</em> mutation analysis</td> </tr> <tr> <td class="indent1">SIFD (ARCSA with immunodeficiency)</td> <td>Family history; infancy or childhood presentation; immunodeficiency; fevers; developmental delay</td> <td><em>TRNT1</em> mutation analysis</td> </tr> <tr> <td class="indent1">Erythropoietic protoporphyria (EPP)</td> <td>Family history; photosensitivity; hepatobiliary complications</td> <td>Total and metal-free erythrocyte protoporphyrin level; <em>FECH</em> mutation analysis</td> </tr> <tr> <td class="subtitle2_left" colspan="3">MCV normal or increased (microcytic RBCs may also be present)</td> </tr> <tr> <td class="indent1">Alcoholism</td> <td>History of alcohol abuse; stigmata of liver disease</td> <td>Response to discontinuation; exclude nutrient deficiencies</td> </tr> <tr> <td class="indent1">Certain medications</td> <td>History of use</td> <td>Response to discontinuation</td> </tr> <tr> <td class="indent1">Copper deficiency</td> <td>Malabsorption; gastrointestinal surgery; zinc ingestion</td> <td>Serum copper and ceruloplasmin levels; zinc level</td> </tr> <tr> <td class="indent1">XLSA in females</td> <td>Family history (no syndromic features)</td> <td><em>ALAS2</em> mutation analysis</td> </tr> <tr> <td class="indent1">MLASA and MLASA variants</td> <td>Family history; +/â€“ infancy or childhood presentation; myopathy; lactic acidosis</td> <td><em>PUS1,</em> <em>YARS2</em>, <em>LARS2</em>, IARS2, SARS2, <em>MT-ATP6</em> mutation analysis</td> </tr> <tr> <td class="indent1">X-linked MLASA variant</td> <td>Family history; childhood presentation; variable syndromic features</td> <td><em>NDUFB11</em> mutation analysis</td> </tr> <tr> <td class="indent1">Pearson marrow-pancreas syndrome</td> <td>Infancy or childhood presentation; pancreatic insufficiency; acidosis</td> <td>Mitochondrial DNA mutation analysis</td> </tr> <tr> <td class="indent1">TRMA</td> <td>Family history; infancy or childhood presentation; diabetes mellitus; deafness</td> <td><em>SLC19A2</em> mutation analysis</td> </tr> <tr> <td class="indent1">MDS-RS-SLD</td> <td>Anemia without other cytopenias</td> <td>Exclusion of other causes; <em>SF3B1</em> mutation analysis</td> </tr> <tr> <td class="indent1">MDS-RS-MLD</td> <td>Anemia with leukopenia and/or thrombocytopenia</td> <td>Exclusion of other causes; <em>SF3B1</em> mutation analysis</td> </tr> <tr> <td class="indent1">MDS/MPN-RS-T</td> <td>Anemia with thrombocytosis</td> <td>Exclusion of other causes; <em>SF3B1</em> and <em>JAK2</em> V617F mutation analysis</td> </tr> </tbody></table></div><div class="graphic_lgnd">This table applies to patients for whom ring sideroblasts are present in a Prussian blue stained smear of the bone marrow aspirate. The MCV is most accurate before the patient has received any transfusion. Additional forms of sideroblastic anemia exist for which the cause has not yet been identified. Refer to UpToDate for discussions of the evaluation and management of sideroblastic anemia.</div><div class="graphic_footnotes">MCV: mean corpuscular volume; 
	XLSA: X-linked sideroblastic anemia; 
	XLSA/A: X-linked sideroblastic anemia and ataxia; 
	ARCSA: autosomal recessive congenital sideroblastic anemia; 
	SIFD: sideroblastic anemia with B cell immunodeficiency, periodic fevers, and developmental delay; 
	RBC: red blood cell; 
	MLASA: myopathy, lactic acidosis, and sideroblastic anemia; 
	TRMA: thiamine-responsive megaloblastic anemia; 
	MDS-RS-SLD: myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia; 
	MDS-RS-MLD: myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia; 
	MDS/MPN-RS-T: myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.</div><div id="graphicVersion">Graphic 108664 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
